Although its roles as an immune checkpoint in immune and tumor cells have gained much attention, the role of TIM-3 in metabolic reprogramming of immune and cancer cells in the context of HCC has not yet been thoroughly investigated. The gene discussed is HAVCR2; the disease is cancer.